ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Apomorphine Hydrochloride Market Research Report 2026
Published Date: 2026-02-25
|
Report Code: QYRE-Auto-2C9445
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Apomorphine Hydrochloride Market Outlook 2022
BUY CHAPTERS

Global Apomorphine Hydrochloride Market Research Report 2026

Code: QYRE-Auto-2C9445
Report
2026-02-25
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Stada Arzneimittel
Aguettant
Italfarmaco S.p.A.
Sumitomo Pharma
Hubei Keyi Pharma

Apomorphine Hydrochloride Market Size

The global Apomorphine Hydrochloride market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 217 million by 2032, at a CAGR of 4.5% from 2026 to 2032.

Apomorphine Hydrochloride Market

Apomorphine Hydrochloride Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Apomorphine Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report delivers a comprehensive overview of the global Apomorphine Hydrochloride market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Apomorphine Hydrochloride. The Apomorphine Hydrochloride market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Apomorphine Hydrochloride manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Apomorphine Hydrochloride Market Report

Report Metric Details
Report Name Apomorphine Hydrochloride Market
Accounted market size in 2025 US$ 160 million
Forecasted market size in 2032 US$ 217 million
CAGR 4.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Injection
  • Tablets
  • Thinfilm
  • Nasal Powder (Pipeline)
by Application
  • Parkinson Disease
  • Erectile Dysfunction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion, STADA Arzneimittel, Aguettant, Italfarmaco, Sumitomo Pharma, Hubei Keyi Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Apomorphine Hydrochloride manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Apomorphine Hydrochloride sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Apomorphine Hydrochloride Market growing?

Ans: The Apomorphine Hydrochloride Market witnessing a CAGR of 4.5% during the forecast period 2026-2032.

What is the Apomorphine Hydrochloride Market size in 2032?

Ans: The Apomorphine Hydrochloride Market size in 2032 will be US$ 217 million.

What is the Apomorphine Hydrochloride Market share by application?

Ans: The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

What is the Apomorphine Hydrochloride Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019.

Who are the main players in the Apomorphine Hydrochloride Market report?

Ans: The main players in the Apomorphine Hydrochloride Market are Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion, STADA Arzneimittel, Aguettant, Italfarmaco, Sumitomo Pharma, Hubei Keyi Pharma

What are the Application segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Applications covered in the Apomorphine Hydrochloride Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Types covered in the Apomorphine Hydrochloride Market report are Injection, Tablets, Thinfilm, Nasal Powder (Pipeline)

1 Apomorphine Hydrochloride Market Overview
1.1 Product Definition
1.2 Apomorphine Hydrochloride by Type
1.2.1 Global Apomorphine Hydrochloride Market Value by Type: 2025 vs 2032
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 Apomorphine Hydrochloride by Application
1.3.1 Global Apomorphine Hydrochloride Market Value by Application: 2025 vs 2032
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Revenue 2021–2032
1.4.2 Global Apomorphine Hydrochloride Sales 2021–2032
1.4.3 Global Apomorphine Hydrochloride Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride Market Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2021–2026)
2.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride, Product Types and Applications
2.7 Global Key Manufacturers of Apomorphine Hydrochloride, Date of Entry into the Industry
2.8 Global Apomorphine Hydrochloride Market Competitive Situation and Trends
2.8.1 Global Apomorphine Hydrochloride Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Apomorphine Hydrochloride Players Market Share by Revenue
2.8.3 Global Apomorphine Hydrochloride Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Apomorphine Hydrochloride Market Scenario by Region
3.1 Global Apomorphine Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Apomorphine Hydrochloride Sales by Region: 2021–2032
3.2.1 Global Apomorphine Hydrochloride Sales by Region: 2021–2026
3.2.2 Global Apomorphine Hydrochloride Sales by Region: 2027–2032
3.3 Global Apomorphine Hydrochloride Revenue by Region: 2021–2032
3.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2021–2026
3.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2027–2032
3.4 North America Apomorphine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Apomorphine Hydrochloride Sales by Country (2021–2032)
3.4.3 North America Apomorphine Hydrochloride Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Apomorphine Hydrochloride Sales by Country (2021–2032)
3.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Region
3.6.1 Asia Pacific Apomorphine Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Region (2021–2032)
3.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Apomorphine Hydrochloride Sales by Country (2021–2032)
3.7.3 Latin America Apomorphine Hydrochloride Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2021–2032)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Sales by Type (2021–2032)
4.1.1 Global Apomorphine Hydrochloride Sales by Type (2021–2026)
4.1.2 Global Apomorphine Hydrochloride Sales by Type (2027–2032)
4.1.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2021–2032)
4.2 Global Apomorphine Hydrochloride Revenue by Type (2021–2032)
4.2.1 Global Apomorphine Hydrochloride Revenue by Type (2021–2026)
4.2.2 Global Apomorphine Hydrochloride Revenue by Type (2027–2032)
4.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2021–2032)
4.3 Global Apomorphine Hydrochloride Price by Type (2021–2032)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Sales by Application (2021–2032)
5.1.1 Global Apomorphine Hydrochloride Sales by Application (2021–2026)
5.1.2 Global Apomorphine Hydrochloride Sales by Application (2027–2032)
5.1.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2021–2032)
5.2 Global Apomorphine Hydrochloride Revenue by Application (2021–2032)
5.2.1 Global Apomorphine Hydrochloride Revenue by Application (2021–2026)
5.2.2 Global Apomorphine Hydrochloride Revenue by Application (2027–2032)
5.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2021–2032)
5.3 Global Apomorphine Hydrochloride Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Company Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Company Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Company Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Company Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Company Information
6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
6.6 Sunovion
6.6.1 Sunovion Company Information
6.6.2 Sunovion Description and Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments/Updates
6.7 STADA Arzneimittel
6.7.1 STADA Arzneimittel Company Information
6.7.2 STADA Arzneimittel Description and Business Overview
6.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 STADA Arzneimittel Apomorphine Hydrochloride Product Portfolio
6.7.5 STADA Arzneimittel Recent Developments/Updates
6.8 Aguettant
6.8.1 Aguettant Company Information
6.8.2 Aguettant Description and Business Overview
6.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Aguettant Apomorphine Hydrochloride Product Portfolio
6.8.5 Aguettant Recent Developments/Updates
6.9 Italfarmaco
6.9.1 Italfarmaco Company Information
6.9.2 Italfarmaco Description and Business Overview
6.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Italfarmaco Apomorphine Hydrochloride Product Portfolio
6.9.5 Italfarmaco Recent Developments/Updates
6.10 Sumitomo Pharma
6.10.1 Sumitomo Pharma Company Information
6.10.2 Sumitomo Pharma Description and Business Overview
6.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sumitomo Pharma Apomorphine Hydrochloride Product Portfolio
6.10.5 Sumitomo Pharma Recent Developments/Updates
6.11 Hubei Keyi Pharma
6.11.1 Hubei Keyi Pharma Company Information
6.11.2 Hubei Keyi Pharma Description and Business Overview
6.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolio
6.11.5 Hubei Keyi Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Industry Chain Analysis
7.2 Apomorphine Hydrochloride Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Production Mode & Process Analysis
7.4 Apomorphine Hydrochloride Sales and Marketing
7.4.1 Apomorphine Hydrochloride Sales Channels
7.4.2 Apomorphine Hydrochloride Distributors
7.5 Apomorphine Hydrochloride Customer Analysis
8 Apomorphine Hydrochloride Market Dynamics
8.1 Apomorphine Hydrochloride Industry Trends
8.2 Apomorphine Hydrochloride Market Drivers
8.3 Apomorphine Hydrochloride Market Challenges
8.4 Apomorphine Hydrochloride Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Stada Arzneimittel
Aguettant
Italfarmaco S.p.A.
Sumitomo Pharma
Hubei Keyi Pharma
List of Tables
 Table 1. Global Apomorphine Hydrochloride Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Apomorphine Hydrochloride Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Apomorphine Hydrochloride Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Apomorphine Hydrochloride Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Apomorphine Hydrochloride Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Apomorphine Hydrochloride Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Apomorphine Hydrochloride Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Apomorphine Hydrochloride, Product Types and Applications
 Table 12. Global Key Manufacturers of Apomorphine Hydrochloride, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Apomorphine Hydrochloride Companies by Tier (Tier 1, Tier 2, Tier 3), based on Apomorphine Hydrochloride Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Apomorphine Hydrochloride Sales by Region (K Units), 2021–2026
 Table 18. Global Apomorphine Hydrochloride Sales Market Share by Region (2021–2026)
 Table 19. Global Apomorphine Hydrochloride Sales by Region (K Units), 2027–2032
 Table 20. Global Apomorphine Hydrochloride Sales Market Share by Region (2027–2032)
 Table 21. Global Apomorphine Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Apomorphine Hydrochloride Revenue Market Share by Region (2021–2026)
 Table 23. Global Apomorphine Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Apomorphine Hydrochloride Revenue Market Share by Region (2027–2032)
 Table 25. North America Apomorphine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Apomorphine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 27. North America Apomorphine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 28. North America Apomorphine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Apomorphine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Apomorphine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Apomorphine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 32. Europe Apomorphine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 33. Europe Apomorphine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Apomorphine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Apomorphine Hydrochloride Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Apomorphine Hydrochloride Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Apomorphine Hydrochloride Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Apomorphine Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Apomorphine Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Apomorphine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Apomorphine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 42. Latin America Apomorphine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 43. Latin America Apomorphine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Apomorphine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Apomorphine Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Apomorphine Hydrochloride Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Apomorphine Hydrochloride Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Apomorphine Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Apomorphine Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Apomorphine Hydrochloride Sales (K Units) by Type (2021–2026)
 Table 51. Global Apomorphine Hydrochloride Sales (K Units) by Type (2027–2032)
 Table 52. Global Apomorphine Hydrochloride Sales Market Share by Type (2021–2026)
 Table 53. Global Apomorphine Hydrochloride Sales Market Share by Type (2027–2032)
 Table 54. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Apomorphine Hydrochloride Revenue Market Share by Type (2021–2026)
 Table 57. Global Apomorphine Hydrochloride Revenue Market Share by Type (2027–2032)
 Table 58. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Apomorphine Hydrochloride Sales (K Units) by Application (2021–2026)
 Table 61. Global Apomorphine Hydrochloride Sales (K Units) by Application (2027–2032)
 Table 62. Global Apomorphine Hydrochloride Sales Market Share by Application (2021–2026)
 Table 63. Global Apomorphine Hydrochloride Sales Market Share by Application (2027–2032)
 Table 64. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Apomorphine Hydrochloride Revenue Market Share by Application (2021–2026)
 Table 67. Global Apomorphine Hydrochloride Revenue Market Share by Application (2027–2032)
 Table 68. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2027–2032)
 Table 70. Supernus Pharmaceuticals Company Information
 Table 71. Supernus Pharmaceuticals Description and Business Overview
 Table 72. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Supernus Pharmaceuticals Apomorphine Hydrochloride Product
 Table 74. Supernus Pharmaceuticals Recent Developments/Updates
 Table 75. Britannia Pharmaceuticals STADA Company Information
 Table 76. Britannia Pharmaceuticals STADA Description and Business Overview
 Table 77. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product
 Table 79. Britannia Pharmaceuticals STADA Recent Developments/Updates
 Table 80. Ever Pharma Company Information
 Table 81. Ever Pharma Description and Business Overview
 Table 82. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Ever Pharma Apomorphine Hydrochloride Product
 Table 84. Ever Pharma Recent Developments/Updates
 Table 85. Evolan Pharma AB (PharmSwed) Company Information
 Table 86. Evolan Pharma AB (PharmSwed) Description and Business Overview
 Table 87. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product
 Table 89. Evolan Pharma AB (PharmSwed) Recent Developments/Updates
 Table 90. Tianjin Tianwei Pharmaceutical Company Information
 Table 91. Tianjin Tianwei Pharmaceutical Description and Business Overview
 Table 92. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product
 Table 94. Tianjin Tianwei Pharmaceutical Recent Developments/Updates
 Table 95. Sunovion Company Information
 Table 96. Sunovion Description and Business Overview
 Table 97. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Sunovion Apomorphine Hydrochloride Product
 Table 99. Sunovion Recent Developments/Updates
 Table 100. STADA Arzneimittel Company Information
 Table 101. STADA Arzneimittel Description and Business Overview
 Table 102. STADA Arzneimittel Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. STADA Arzneimittel Apomorphine Hydrochloride Product
 Table 104. STADA Arzneimittel Recent Developments/Updates
 Table 105. Aguettant Company Information
 Table 106. Aguettant Description and Business Overview
 Table 107. Aguettant Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Aguettant Apomorphine Hydrochloride Product
 Table 109. Aguettant Recent Developments/Updates
 Table 110. Italfarmaco Company Information
 Table 111. Italfarmaco Description and Business Overview
 Table 112. Italfarmaco Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Italfarmaco Apomorphine Hydrochloride Product
 Table 114. Italfarmaco Recent Developments/Updates
 Table 115. Sumitomo Pharma Company Information
 Table 116. Sumitomo Pharma Description and Business Overview
 Table 117. Sumitomo Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Sumitomo Pharma Apomorphine Hydrochloride Product
 Table 119. Sumitomo Pharma Recent Developments/Updates
 Table 120. Hubei Keyi Pharma Company Information
 Table 121. Hubei Keyi Pharma Description and Business Overview
 Table 122. Hubei Keyi Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Hubei Keyi Pharma Apomorphine Hydrochloride Product
 Table 124. Hubei Keyi Pharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Apomorphine Hydrochloride Distributors List
 Table 128. Apomorphine Hydrochloride Customers List
 Table 129. Apomorphine Hydrochloride Market Trends
 Table 130. Apomorphine Hydrochloride Market Drivers
 Table 131. Apomorphine Hydrochloride Market Challenges
 Table 132. Apomorphine Hydrochloride Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Apomorphine Hydrochloride
 Figure 2. Global Apomorphine Hydrochloride Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Apomorphine Hydrochloride Market Share by Type: 2025 & 2032
 Figure 4. Injection Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Thinfilm Product Picture
 Figure 7. Nasal Powder (Pipeline) Product Picture
 Figure 8. Global Apomorphine Hydrochloride Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Apomorphine Hydrochloride Market Share by Application: 2025 & 2032
 Figure 10. Parkinson Disease
 Figure 11. Erectile Dysfunction
 Figure 12. Global Apomorphine Hydrochloride Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Apomorphine Hydrochloride Market Size (US$ Million), 2021–2032
 Figure 14. Global Apomorphine Hydrochloride Sales (K Units), 2021–2032
 Figure 15. Global Apomorphine Hydrochloride Average Price (USD/Unit), 2021–2032
 Figure 16. Apomorphine Hydrochloride Report Years Considered
 Figure 17. Apomorphine Hydrochloride Sales Share by Manufacturers in 2025
 Figure 18. Global Apomorphine Hydrochloride Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Apomorphine Hydrochloride Players: Market Share by Revenue in Apomorphine Hydrochloride in 2025
 Figure 20. Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Apomorphine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 23. North America Apomorphine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Apomorphine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 27. Europe Apomorphine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Apomorphine Hydrochloride Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Apomorphine Hydrochloride Revenue Market Share by Region (2021–2032)
 Figure 35. China Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Apomorphine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Apomorphine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Apomorphine Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Apomorphine Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Apomorphine Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Apomorphine Hydrochloride by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Apomorphine Hydrochloride by Type (2021–2032)
 Figure 57. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Apomorphine Hydrochloride by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Apomorphine Hydrochloride by Application (2021–2032)
 Figure 60. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2021–2032)
 Figure 61. Apomorphine Hydrochloride Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Apomorphine Hydrochloride Injection Market Insights Forecast to 2030
Global Apomorphine Delivery Device Market Insights Forecast to 2030
Global Dopamine Agonists Market Research Report 2024
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dopamine Receptor Agonists Market Research Report 2025
Global Dopamine Receptor Agonists For PD Market Research Report 2025
Global Tiapride Market Insights Forecast to 2030
Global Dopamine Hydrochloride API Market Research Report 2025
Global Lurasidone Hydrochloride API Market Research Report 2024
Global Tiapride Hydrochloride Tablets Market Research Report 2024
Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hydromorphone Hydrochloride Injection Market Research Report 2024
Global Selegiline Hydrochloride Market Research Report 2024
Global Agomelatine Market Research Report 2024
Global Dopamine Impurity Market Research Report 2025
Global Norepinephrine Noradrenaline Market Insights Forecast to 2030
Global Imipramine HCL API Market Research Report 2025
Global Levodopa Market Insights Forecast to 2030
Global Opioid Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions